As at Apr 26, 2024, the MRK stock has a PE ratio of 937.14. This is based on the current EPS of $0.14 and the stock price of $131.2 per share. The current PE ratio is comparable to the past four-quarter average.
The mean historical PE ratio of Merck over the last ten years is 53.63. The current 937.14 P/E ratio is similar to the historical average. In the past ten years, MRK's PE ratio peaked in the Dec 2023 quarter at 778.71, with a price of $109.02 and an EPS of $0.14. The Sep 2015 quarter marked the lowest point at 13.1, with a price of $49.39 and an EPS of $3.77.
Maximum annual increase: 3,922.26% in 2023
Maximum annual decrease: -58.98% in 2014
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 778.71 | 3,922.26% |
| 2022 | 19.36 | 30.37% |
| 2021 | 14.85 | -49.35% |
| 2020 | 29.32 | 23.82% |
| 2019 | 23.68 | -27.47% |
| 2018 | 32.65 | -48.94% |
| 2017 | 63.94 | 54.22% |
| 2016 | 41.46 | 24.02% |
| 2015 | 33.43 | 142.6% |
| 2014 | 13.78 | -58.98% |
The current PE ratio of MRK is above the 3, 5 and 10-year averages.
MRK's PE ratio stands higher than its peer stocks LLY and JNJ. Merck's current PE ratio of 937.14 is similar to the average of its peer group, which is 28.96.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.53 | $352.02B |
| NVS Novartis AG | 13.15 | $198.82B |
| AMGN Amgen Inc | 21.5 | $144.69B |
| ABT Abbott Laboratories | 32.78 | $186.58B |
| PFE Pfizer Inc | 66.84 | $143.43B |
| LLY ELI LILLY & Co | 126.03 | $696.96B |
| MRK Merck & Co Inc | 937.14 | $332.28B |
| BMY Bristol Myers Squibb Co | N/A | $90.92B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $15.48B |
As of Apr 26, 2024, MRK stock has a price to earnings ratio of 937.14.
The average PE ratio for MRK stock over the past 3 years is 99.06.
The average PE ratio for MRK stock over the past 5 years is 67.01.
Within the last ten years, the current PE ratio is at its peak with a value of 937.14.
MRK's current price to earnings ratio is 1,647% above its 10-year historical average.
MRK's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 26, 2024), Merck's stock price is $131.2. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $0.14. Therefore, Merck's PE ratio for today is 937.14. PE RATIO(937.14) = STOCK PRICE($131.2) / TTM EPS($0.14)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.